NM MPJE key terms

New Mexico statute (NMSA Chapter 61, Article 11) that defines the practice of pharmacy, sets licensing requirements, and grants the Board of Pharmacy authority to adopt rules and enforce compliance.

The New Mexico regulatory body that licenses pharmacies and pharmacy personnel, adopts rules under the Practice Act, inspects practice sites, investigates complaints, and imposes discipline when violations are found.

A formal Board pleading stating the allegations against a licensee and the discipline the Board proposes, which triggers the licensee's right to request a hearing before the action becomes final.

Process by which a pharmacist already licensed in another state obtains a New Mexico license based on verified licensure and examination history, subject to any additional Board requirements.

Professional education hours a licensee must complete during each renewal cycle to keep a license active; the Board sets the number of hours, acceptable subject matter, and documentation standards.

A person registered with the Board who is earning supervised practice hours toward licensure and may perform pharmacist duties only under the supervision of an approved preceptor.

A Board-registered support person who assists pharmacists with dispensing and related tasks under supervision, with permitted duties and supervision ratios established by Board rule.

Board-issued authorization that a specific location must hold before operating as a pharmacy; it identifies the practice type and must be renewed, and ownership or location changes require notice.

The pharmacist designated to a licensed pharmacy who is accountable to the Board for the site's compliance, staffing, security, records, and daily operations, including supervision of technicians and interns.

Federal statute (21 U.S.C. 801 et seq.) that classifies controlled substances into five schedules and imposes registration, ordering, security, recordkeeping, and prescription requirements enforced by DEA.

Federal certificate authorizing a practitioner or pharmacy to handle controlled substances; it is separate from state licensure, must be renewed periodically, and may be restricted, surrendered, or revoked.

State authorization, issued through the Board of Pharmacy, permitting a practitioner or facility to handle controlled substances in New Mexico; it is required in addition to a federal DEA registration.

Controlled substance category with high abuse potential and accepted medical use; prescriptions may not be refilled and are subject to stricter written, quantity, and emergency-oral requirements.

Statewide database of dispensed controlled substances that prescribers and pharmacists query to identify misuse; dispensers must report regularly and query obligations are set by state law and rule.

A complete count of controlled substances on hand that a registrant must perform every two years, with additional inventories when newly scheduled drugs are acquired, retained for inspection.

The paper or electronic order document used to transfer Schedule I and II substances between registrants; it must be completed accurately, kept as an accountability record, and not altered after use.

A lawful written, electronic, or oral order from an authorized prescriber for a specific patient that permits dispensing of a drug, containing the elements required by statute and Board rule.

A telephone order for a Schedule II drug allowed only in defined emergency situations, which the prescriber must follow with a written or electronic prescription within the federal time limit.

Movement of a valid, refillable prescription between pharmacies at the patient's request, with rules governing the information exchanged and the records each pharmacy must keep.

Information that must appear on a dispensed container, such as patient and prescriber names, drug name and strength, directions, quantity, date filled, and pharmacy identifiers.

Dispensing a therapeutically equivalent lower-cost product instead of the prescribed brand; state law defines when substitution is permitted and what the patient or prescriber must be told.

A drug that federal or state law requires to be dispensed only on a valid prescription; selling or dispensing it without prescriber authorization is unlawful.

Screening a prescription before dispensing for interactions, therapeutic duplication, dose problems, and allergies, with the pharmacist's resulting actions documented in the patient record.

Discussion with the patient or caregiver about proper use, storage, expected effects, and precautions; it is required unless declined and should be documented in the pharmacy record.

A practice model in which the pharmacist accepts responsibility for a patient's drug therapy outcomes, identifying and resolving drug-related problems rather than only preparing and dispensing products.

A New Mexico credential that allows a pharmacist with qualifying training to exercise prescriptive authority and manage patient therapy under Board rules, including specified limits and oversight.

A written arrangement between a pharmacist and a prescriber or authorized protocol that defines which drugs the pharmacist may initiate, adjust, or continue and what monitoring and documentation are required.

Administration of vaccines by a trained and authorized pharmacist or technician under Board rules, including age limits, emergency procedures, and reporting doses to the state immunization registry.

Preparing a customized medication by combining, diluting, or altering ingredients pursuant to a patient-specific prescription; federal law plus Board and USP standards govern the practice and its records.

Standards for nonsterile compounding addressing facility design, personnel training, ingredient and equipment handling, and assignment of beyond-use dates for the finished preparation.

Sterile compounding standards covering cleanroom design, environmental monitoring, garbing, aseptic technique, and process validation that a pharmacy must meet when preparing sterile preparations.

The date after which a compounded preparation may no longer be used, calculated from the formulation, container, storage conditions, and applicable USP default limits.

An ongoing, documented program to detect, analyze, and prevent dispensing errors and other quality-related events, using nonpunitive reporting and periodic review of findings and corrective actions.

Federal law requiring an interoperable electronic system to trace prescription drug packages through the supply chain, with serialization, verification, and trading-partner licensure checks by pharmacies.

Federal privacy and security rules limiting how a pharmacy may use or disclose protected health information, giving patients access rights, and requiring safeguards and breach notification.

Requirement to keep prescription, controlled substance, purchasing, and inspection records for specified periods and to make them readily retrievable for Board or DEA review.

Review of a pharmacy's premises, records, and practices by Board or DEA personnel; it may be announced or unannounced, and findings can lead to corrective action plans or discipline.